鲍曼不动杆菌
美罗培南
粪肠球菌
微生物学
利奈唑啉
抗生素耐药性
肠球菌
铜绿假单胞菌
肺炎克雷伯菌
抗药性
万古霉素
不动杆菌
抗生素
屎肠球菌
医学
金黄色葡萄球菌
生物
大肠杆菌
细菌
遗传学
生物化学
基因
作者
Yang Junlin,Li Lingzhu,Guangying Luo,Meng Huaqing,Zha Zhuhong
标识
DOI:10.36721/pjps.2023.36.3.reg.723-730.1
摘要
To understand the changes of resistance of major clinical isolates to commonly used antibiotics in a comprehensive teaching hospital from 2015 to 2017 and to provide a basis for rational clinical use of antibiotics in the hospital. Antimicrobial susceptibility testing of all clinical isolates from 2015 to 2017 was carried out according to a unified protocol using Kirby-Bauer method or automated systems according to the unified plan. A total of 28715 non-repetitive clinical isolates were collected from 2015 to 2017. Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii were the top three most common isolates for three consecutive years. Escherichia coli is still highly sensitive to carbapenems, with the drug resistance rate less than 1%. Klebsiella pneumoniae's resistance to carbapenems increases year by year, reaching about 18% in 2017. The resistance rate of Acinetobacter baumannii to meropenem was above 70%, and that of Pseudomonas aeruginosa to meropenem was about 30%. Staphylococcus is more sensitive to linezolid and vancomycin. Enterococcus faecalis had lower drug resistance to most tested antibiotics (except tetracycline) than Enterococcus faecalis, and both were sensitive to linezolid and vancomycin. Bacterial resistance to commonly used antibiotics is still on the rise. We should strengthen the management of clinical use of antimicrobial agents and maintain good practice in surveillance of bacterial resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI